Abbott India Reports Strong Financial Results Amid Evaluation Adjustment in August 2025

Aug 12 2025 03:54 PM IST
share
Share Via
Abbott India has announced its financial results for the quarter ending June 2025, revealing record net sales of Rs 1,738.35 crore and an operating profit of Rs 445.59 crore. The profit before tax also reached Rs 420.29 crore, reflecting strong operational efficiency and effective cost management.
Abbott India, a midcap player in the Pharmaceuticals & Biotechnology sector, has recently reported its financial results for the quarter ending June 2025. The results, declared on August 12, 2025, indicate a notable performance in several key areas.

Net sales reached Rs 1,738.35 crore, marking the highest figure recorded in the last five quarters. This positive trend in sales reflects a robust demand for Abbott India's products. Additionally, the operating profit (PBDIT) also peaked at Rs 445.59 crore during the same period, showcasing strong operational efficiency. Furthermore, the profit before tax (PBT) reached Rs 420.29 crore, again the highest in the last five quarters, indicating effective cost management and revenue generation strategies.

Despite these positive indicators, Abbott India has experienced an adjustment in its evaluation, with the score reflecting a shift from 5 to 3 over the past three months. This revision highlights the dynamic nature of the company's performance assessment in the context of its recent financial results.

For more insights, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Abbott India Ltd. is Rated Sell
Dec 24 2025 08:23 PM IST
share
Share Via
Why is Abbott India falling/rising?
Dec 09 2025 12:47 AM IST
share
Share Via
Is Abbott India technically bullish or bearish?
Dec 03 2025 08:39 AM IST
share
Share Via
How has been the historical performance of Abbott India?
Dec 02 2025 10:58 PM IST
share
Share Via